{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["FLI1", "N-WASP", "WASP", "WIP", "Wiskott\u2013Aldrich Syndrome", "immunodeficiency", "megakaryopoiesis", "microthrombocytopenia"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33717090", "DateCompleted": {"Year": "2021", "Month": "07", "Day": "05"}, "DateRevised": {"Year": "2021", "Month": "07", "Day": "05"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "02", "Day": "26"}], "Language": ["eng"], "ELocationID": ["607836", "10.3389/fimmu.2021.607836"], "Journal": {"ISSN": "1664-3224", "JournalIssue": {"Volume": "12", "PubDate": {"Year": "2021"}}, "Title": "Frontiers in immunology", "ISOAbbreviation": "Front Immunol"}, "ArticleTitle": "FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich Syndrome.", "Pagination": {"StartPage": "607836", "MedlinePgn": "607836"}, "Abstract": {"AbstractText": ["Wiskott-Aldrich Syndrome, WAS/WAVE, is a rare, X-linked immune-deficiency disease caused by mutations in the <i>WAS</i> gene, which together with its homolog, N-<i>WASP</i>, regulates actin cytoskeleton remodeling and cell motility. WAS patients suffer from microthrombocytopenia, characterized by a diminished number and size of platelets, though the underlying mechanism is not fully understood. Here, we identified FLI1 as a direct transcriptional regulator of <i>WAS</i> and its binding partner <i>WIP</i>. Depletion of either <i>WAS</i> or <i>WIP</i> in human erythroleukemic cells accelerated cell proliferation, suggesting tumor suppressor function of both genes in leukemia. Depletion of <i>WAS/WIP</i> also led to a significant reduction in the percentage of CD41 and CD61 positive cells, which mark committed megakaryocytes. RNAseq analysis revealed common changes in megakaryocytic gene expression following FLI1 or WASP knockdown. However, in contrast to FLI1, WASP depletion did not alter expression of late-stage platelet-inducing genes. N-WASP was not regulated by FLI1, yet its silencing also reduced the percentage of CD41+ and CD61+ megakaryocytes. Moreover, combined knockdown of WASP and N-WASP further suppressed megakaryocyte differentiation, indicating a major cooperation of these related genes in controlling megakaryocytic cell fate. However, unlike WASP/WIP, N-WASP loss suppressed leukemic cell proliferation. WASP, WIP and N-WASP depletion led to induction of FLI1 expression, mediated by GATA1, and this may mitigate the severity of platelet deficiency in WAS patients. Together, these results uncover a crucial role for FLI1 in megakaryocyte differentiation, implicating this transcription factor in regulating microthrombocytopenia associated with Wiskott-Aldrich syndrome."], "CopyrightInformation": "Copyright \u00a9 2021 Wang, Sample, Gajendran, Kapranov, Liu, Hu, Zacksenhaus, Li, Hao and Ben-David."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, China."}], "LastName": "Wang", "ForeName": "Chunlin", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The National Health Commission's Key Laboratory of Immunological Pulmonary Disease, Guizhou Provincial People's Hospital, The Affiliated Hospital of Guizhou University, Guiyang, China."}], "LastName": "Sample", "ForeName": "Klarke M", "Initials": "KM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, China."}], "LastName": "Gajendran", "ForeName": "Babu", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Biomedical Sciences, Institute of Genomics, Huaqiao University, Xiamen, China."}], "LastName": "Kapranov", "ForeName": "Philipp", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, China."}], "LastName": "Liu", "ForeName": "Wuling", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, China."}], "LastName": "Hu", "ForeName": "Anling", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, University of Toronto, Toronto, ON, Canada."}, {"Identifier": [], "Affiliation": "Division of Advanced Diagnostics, Toronto General Research Institute-University Health Network, Toronto, ON, Canada."}], "LastName": "Zacksenhaus", "ForeName": "Eldad", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, China."}], "LastName": "Li", "ForeName": "Yanmei", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, China."}], "LastName": "Hao", "ForeName": "Xiaojiang", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, China."}], "LastName": "Ben-David", "ForeName": "Yaacov", "Initials": "Y"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Immunol", "NlmUniqueID": "101560960", "ISSNLinking": "1664-3224"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biomarkers"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytoskeletal Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "FLI1 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Intracellular Signaling Peptides and Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Proto-Oncogene Protein c-fli-1"}, {"RegistryNumber": "0", "NameOfSubstance": "WAS protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "WIPF1 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Wiskott-Aldrich Syndrome Protein"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Base Sequence"}, {"QualifierName": [], "DescriptorName": "Biomarkers"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": [], "DescriptorName": "Chromatin Immunoprecipitation Sequencing"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytoskeletal Proteins"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Disease Susceptibility"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Intracellular Signaling Peptides and Proteins"}, {"QualifierName": ["genetics", "metabolism", "pathology"], "DescriptorName": "Leukemia"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Knockout"}, {"QualifierName": [], "DescriptorName": "Promoter Regions, Genetic"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Proto-Oncogene Protein c-fli-1"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["genetics"], "DescriptorName": "Thrombopoiesis"}, {"QualifierName": ["etiology", "metabolism"], "DescriptorName": "Wiskott-Aldrich Syndrome"}, {"QualifierName": ["metabolism"], "DescriptorName": "Wiskott-Aldrich Syndrome Protein"}], "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ochs HD, Thrasher AJ. The Wiskott-Aldrich syndrome. Allergy Clin Immunol (2006) 117:725\u201338. 10.1016/j.jaci.2006.02.005", "ArticleIdList": ["10.1016/j.jaci.2006.02.005", "16630926"]}, {"Citation": "Jin Y, Mazza BM, Bosticardo M, Marangoni F, Aiuti A, Villa A, et al. . Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. Blood (2009) 113:6288\u2013295. \u00a010.1182/blood-2008-12-115253", "ArticleIdList": ["10.1182/blood-2008-12-115253", "19351959"]}, {"Citation": "Jin Y, Mazza C, Christie JR, Giliani S, Fiorini M, Mella P, et al. . Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): Hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood (2005) 104:4010\u2013 4019. \u00a010.1182/blood-2003-05-1592", "ArticleIdList": ["10.1182/blood-2003-05-1592", "15284122"]}, {"Citation": "Imai K, Morio T, Zhu Y, Jin Y, Itoh S, Kajiwara M, et al. . Clinical course of patients with WASP gene mutations. Blood (2004) 103:456\u201364. \u00a010.1182/blood-2003-05-1480", "ArticleIdList": ["10.1182/blood-2003-05-1480", "12969986"]}, {"Citation": "Ramesh N, Ant\u00f3n IM, Hartwig JH, Geha RS. WIP, a protein associated with Wiskott-Aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells. Proc Natl Acad Sci USA (1997) 94:14671\u20136. \u00a010.1073/pnas.94.26.14671", "ArticleIdList": ["10.1073/pnas.94.26.14671", "PMC25088", "9405671"]}, {"Citation": "Miki H, Suetsugu S, Takenawa T. WAVE, a novel WASP-family protein involved in actin reorganization induced by Rac. EMBO J (1998) 17:6932\u201341. \u00a010.1093/emboj/17.23.6932", "ArticleIdList": ["10.1093/emboj/17.23.6932", "PMC1171041", "9843499"]}, {"Citation": "Imai K, Nonoyama S, Miki H, Morio T, Fukami K, Zhu Q, et al. . The pleckstrin homology domain of the Wiskott\u2013Aldrich syndrome protein is involved in the organization of actin Cytoskeleton. Clin Immunol (1999) 92:128\u201337. \u00a010.1006/clim.1999.4746", "ArticleIdList": ["10.1006/clim.1999.4746", "10444357"]}, {"Citation": "Symons M, Derry JM, Karlak B, Jiang S, Lemahieu V, McCormick F, et al. . Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell (1996) 84:723\u201334. \u00a010.1016/S0092-8674(00)81050-8", "ArticleIdList": ["10.1016/S0092-8674(00)81050-8", "8625410"]}, {"Citation": "Machesky LM, Insall R. Scar1 and the related Wiskott-Aldrich syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2/3 complex. Curr Biol (1998) 8:1347\u201356. \u00a010.1016/S0960-9822(98)00015-3", "ArticleIdList": ["10.1016/S0960-9822(98)00015-3", "9889097"]}, {"Citation": "Welch MD, Mullins RD. Cellular Control of Actin Nucleation. Annu Rev Cell Dev Biol (2002) 18:247\u201388. \u00a010.1146/annurev.cellbio.18.040202.112133", "ArticleIdList": ["10.1146/annurev.cellbio.18.040202.112133", "12142287"]}, {"Citation": "Li Y, Luo H, Liu T, Zacksenhaus E, Ben-David Y. The ets transcription factor Fli-1 in development, cancer and disease. Oncogene (2015) 34:2022\u201331. \u00a010.1038/onc.2014.162", "ArticleIdList": ["10.1038/onc.2014.162", "PMC5028196", "24909161"]}, {"Citation": "Hart A, Melet F, Grossfeld P, Chien K, Jones C, Tunnacliffe A, et al. . Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity (2000) 13:167\u201377. \u00a010.1016/S1074-7613(00)00017-0", "ArticleIdList": ["10.1016/S1074-7613(00)00017-0", "10981960"]}, {"Citation": "Spyropoulos DD, Pharr PN, Lavenburg KR, Jackers P, Papas TS, Ogawa M, et al. . Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol Cell Biol (2000) 20:5643\u201352. \u00a010.1128/MCB.20.15.5643-5652.2000", "ArticleIdList": ["10.1128/MCB.20.15.5643-5652.2000", "PMC86032", "10891501"]}, {"Citation": "Krishnamurti L, Neglia JP, Nagarajan R, Berry SA, Lohr J, Hirsch B, et al. . Paris-Trousseau syndrome platelets in a child with Jacobsen\u2019s syndrome. Am J Hematol (2001) 66:295\u20139. \u00a010.1002/ajh.1061", "ArticleIdList": ["10.1002/ajh.1061", "11279643"]}, {"Citation": "Favier R, Jondeau K, Boutard P, Grossfeld P, Reinert P, Jones C, et al. . Paris-Trousseau syndrome: clinical, hematological, molecular data of ten new cases. Thromb Haemost (2003) 90:893\u20137. \u00a010.1160/TH03-02-0120", "ArticleIdList": ["10.1160/TH03-02-0120", "14597985"]}, {"Citation": "Wenger SL, Grossfeld PD, Siu BL, Coad JE, Keller FG, Hummel M. Molecular characterization of an 11q interstitial deletion in a patient with the clinical features of Jacobsen syndrome. Am J Med Genet A (2006) 140:704\u20138. \u00a010.1002/ajmg.a.31146", "ArticleIdList": ["10.1002/ajmg.a.31146", "16502431"]}, {"Citation": "Liu T, Yao Y, Zhang G, Wang Y, Deng B, Song J, et al. . A screen for Fli-1 transcriptional modulators identifies PKC agonists that induce erythroid to megakaryocytic differentiation and suppress leukemogenesis. Oncotarget (2016) 8:16728\u201343. \u00a010.18632/oncotarget.14377", "ArticleIdList": ["10.18632/oncotarget.14377", "PMC5369997", "28052010"]}, {"Citation": "Schulze H, Korpal M, Hurov J, Kim S-W, Zhang J, Cantley LC, et al. . Characterization of the megakaryocyte demarcation membrane system and its role in thrombopoiesis. Blood (2006) 107:3868\u201375. \u00a010.1182/blood-2005-07-2755", "ArticleIdList": ["10.1182/blood-2005-07-2755", "PMC1895279", "16434494"]}, {"Citation": "Ben-David Y, Prideaux VR, Chow V, Benchimol S, Bernstein A. Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus. Oncogene (1988) 3:179\u201385. \u00a010.1016/0303-7207(88)90166-9", "ArticleIdList": ["10.1016/0303-7207(88)90166-9", "2842714"]}, {"Citation": "Ben-David Y, Lavigueur A, Cheong GY, Bernstein A. Insertional inactivation of the p53 gene during friend leukemia: a new strategy for identifying tumor suppressor genes. New Biologist (1990) 2:1015\u201323.", "ArticleIdList": ["2101628"]}, {"Citation": "Wong KS, Li YJ, Howard J, Ben-David Y. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence. Oncogene (1999) 18:5525\u201334. \u00a010.1038/sj.onc.1202938", "ArticleIdList": ["10.1038/sj.onc.1202938", "10523829"]}, {"Citation": "Liu T, Xia L, Yao Y, Yan C, Fan Y, Gajendran B, et al. . Identification of diterpenoid compounds that interfere with Fli-1 DNA binding to suppress leukemogenesis. Cell Death Dis (2019) 10):117. \u00a010.1038/s41419-019-1363-1", "ArticleIdList": ["10.1038/s41419-019-1363-1", "PMC6370842", "30741932"]}, {"Citation": "Li YJ, Zhao XJ, Li Y, Vecchiarelli-Federico LM, Datti A, Cheng Y, et al. . Drug-mediated inhibition of Fli-1 for the treatment of leukemia. Blood Cancer J (2012) 2:e54. \u00a010.1038/bcj.2011.52", "ArticleIdList": ["10.1038/bcj.2011.52", "PMC3270256", "22829238"]}, {"Citation": "Song J, Yuan C, Yang J, Liu T, Yao Y, Xiao X, et al. . Novel flavagline-like compounds with potent Fli-1 inhibitory activity suppress diverse types of leukemia. FEBS J (2018) 285:4631\u201345. \u00a010.1111/febs.14690", "ArticleIdList": ["10.1111/febs.14690", "30387554"]}, {"Citation": "Ghandi M, Huang FW, Jan\u00e9-Valbuena J, Kryukov GV, Lo CC, McDonald ER III, et al. . Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature (2019) 569:503\u20138. \u00a010.1038/s41586-019-1186-3", "ArticleIdList": ["10.1038/s41586-019-1186-3", "PMC6697103", "31068700"]}, {"Citation": "Vetterkind S, Miki H, Takenawa T, Klawitz I, Scheidtmann K-H, Preuss U. The rat homologue of Wiskott-Aldrich syndrome protein (WASP)-interacting protein (WIP) associates with actin filaments, recruits N-WASP from the nucleus, and mediates mobilization of actin from stress fibers in favor of filopodia formation. J Biol Chem (2002) 277:87\u201395. \u00a010.1074/jbc.M104555200", "ArticleIdList": ["10.1074/jbc.M104555200", "11687573"]}, {"Citation": "Moreau V, Frischknecht F, Reckmann I, Vincentelli R, Rabut G, Stewartet D, et al. . A complex of N-WASP and WIP integrates signalling cascades that lead to actin polymerization. Nat Cell Biol (2000) 2:441\u20134. \u00a010.1038/35017080", "ArticleIdList": ["10.1038/35017080", "10878810"]}, {"Citation": "Luthi JN, Gandhi MJ, Drachman JG. X-linked thrombocytopenia caused by a mutation in the Wiskott-Aldrich syndrome (WAS) gene that disrupts interaction with the WAS protein (WASP)-interacting protein (WIP). Exp Hematol (2003) 31):150\u20138. \u00a010.1016/S0301-472X(02)01023-8", "ArticleIdList": ["10.1016/S0301-472X(02)01023-8", "12591280"]}, {"Citation": "Snapper SB, Rosen FS, Mizoguchi E, Cohen P, Khan W, Liu CH, et al. . Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity (1998) 9:81\u201391. \u00a010.1016/S1074-7613(00)80590-7", "ArticleIdList": ["10.1016/S1074-7613(00)80590-7", "9697838"]}, {"Citation": "Menotti M, Ambrogio C, Cheong TC, Pighi C, Mota I, Cassel SH, et al. . Wiskott\u2013Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma. Nat Med (2019) 25:130\u201340. \u00a010.1038/s41591-018-0262-9", "ArticleIdList": ["10.1038/s41591-018-0262-9", "PMC6556382", "30510251"]}, {"Citation": "Vo KK, Jarocha DJ, Lyde RB, Hayes V, Thom CS, Sullivan SK, et al. . FLI1 level during megakaryopoiesis affects thrombopoiesis and platelet biology. Blood (2017) 129:3486\u201394. \u00a010.1182/blood-2017-02-770958", "ArticleIdList": ["10.1182/blood-2017-02-770958", "PMC5492092", "28432223"]}, {"Citation": "Barbeau B, Barat C, Bergeron D, Rassart E. The GATA-1 and Spi-1 transcriptional factors bind to a GATA/EBS dual element in the Fli-1 exon 1. Oncogene (1999) 18:5535\u201345. \u00a010.1038/sj.onc.1202913", "ArticleIdList": ["10.1038/sj.onc.1202913", "10523830"]}, {"Citation": "Shahid M, Tripathi T, Sobia F, Moin S, Siddiqui M, Khan RA. Histamine, Histamine Receptors, and their Role in Immunomodulation: An Updated Systematic Review. Open Immunol J (2009) 2:9\u201341. \u00a010.2174/1874226200902010009", "ArticleIdList": ["10.2174/1874226200902010009"]}, {"Citation": "Lyons JJ. Hereditary Alpha Tryptasemia: Genotyping and Associated Clinical Features. Immunol Allergy Clin North Am (2018) 38:483\u201395. 10.1016/j.iac.2018.04.003", "ArticleIdList": ["10.1016/j.iac.2018.04.003", "PMC6411063", "30007465"]}, {"Citation": "Parikh SS, Litherland SA, Clare-Salzler MJ, Li W, Gulig PA, Southwick FS. CapG\u2013/\u2013 mice have specific host defense defects that render them more susceptible than CapG+/+ mice to listeria monocytogenes Infection but not to Salmonella enterica serovar typhimurium infection. Infect Immun (2003) 71:6582\u201390. \u00a010.1128/IAI.71.11.6582-6590.2003", "ArticleIdList": ["10.1128/IAI.71.11.6582-6590.2003", "PMC219612", "14573680"]}, {"Citation": "Zhou Y, Wang L, Ban X, Zeng T, Zhu Y, Li M, et al. . DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma. Oncogene (2018) 37:1086\u201394. \u00a010.1038/onc.2017.383", "ArticleIdList": ["10.1038/onc.2017.383", "PMC5851108", "29106393"]}, {"Citation": "Pallaoro M, Fejzo MS, Shayesteh L, Blount JL, Caughey GH. Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3\u201d. J Biol Chem (1999) 274:3355\u201362. \u00a010.1074/jbc.274.6.3355", "ArticleIdList": ["10.1074/jbc.274.6.3355", "9920877"]}, {"Citation": "Peterson JR, Bickford LC, Morgan D, Kim AS, Ouerfelli O, Kirschner MW, et al. . Chemical inhibition of N-WASP by stabilization of a native autoinhibited conformation. Nat Struct Mol Biol (2004) 11:747\u201355. \u00a010.1038/nsmb796", "ArticleIdList": ["10.1038/nsmb796", "15235593"]}, {"Citation": "Bompard G, Rabeharivelo G, Morin N. Inhibition of cytokinesis by\u00a0wiskostatin\u00a0does not rely on N-WASP/Arp2/3 complex pathway. BMC Cell Biol (2008) 9:42. \u00a010.1186/1471-2121-9-42", "ArticleIdList": ["10.1186/1471-2121-9-42", "PMC2527559", "18667055"]}, {"Citation": "de la Fuente MA, Sasahara Y, Calamito M, Ant\u00f6n IM, Elkhal A, Gallego MD, et al. . WIP is a chaperone for Wiskott-Aldrich syndrome protein (WASP). Proc Natl Acad Sci USA (2007) 104:926\u201331. \u00a010.1073/pnas.0610275104", "ArticleIdList": ["10.1073/pnas.0610275104", "PMC1783416", "17213309"]}, {"Citation": "Imai K, Nonoyama S, Ochs HD. WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype. Curr Opin Allergy Clin Immunol (2003) 3:427\u201336. \u00a010.1097/01.all.0000104452.09202.9c", "ArticleIdList": ["10.1097/01.all.0000104452.09202.9c", "14612666"]}, {"Citation": "Stockley J, Morgan NV, Bem D, Lowe GC, Lordkipanidz\u00e9 M, Dawood B, et al. . Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects. Blood (2013) 12:4090\u20133. \u00a010.1182/blood-2013-06-506873", "ArticleIdList": ["10.1182/blood-2013-06-506873", "PMC3862284", "24100448"]}, {"Citation": "Zheng JY, Wu SY, Yu XL, Wu M, Lu Q, He S, et al. . The WASP P460S mutation causes a new phenotype of WASP mutations related disorder: X-linked pancytopenia. Blood (2017) 130:1044. \u00a010.1182/blood-2009-09-239087", "ArticleIdList": ["10.1182/blood-2009-09-239087"]}, {"Citation": "Toscano MG, Mu\u00f1oz P, S\u00e1nchez-Gilabert A, Cobo M, Benabdellah K, Anderson P, et al. . Absence of WASp Enhances Hematopoietic and Megakaryocytic Differentiation in a Human Embryonic Stem Cell Model. Mol Ther (2016) 24:342\u201353. \u00a010.1038/mt.2015.196", "ArticleIdList": ["10.1038/mt.2015.196", "PMC4817813", "26502776"]}, {"Citation": "Dalm VA, Driessen GJ, Barendregt BH, van Hagen PM, van der Burg M. The 11q Terminal Deletion Disorder Jacobsen Syndrome is a Syndromic Primary Immunodeficiency. J Clin Immunol (2015) 35(8):761\u20138. \u00a010.1007/s10875-015-0211-z", "ArticleIdList": ["10.1007/s10875-015-0211-z", "PMC4659842", "26566921"]}, {"Citation": "Coppe A, Nogara L, Pizzuto MS, Cani A, Cesaro S, Masetti R, et al. . Somatic mutations activating Wiskott-Aldrich syndrome protein concomitant with RAS pathway mutations in juvenile myelomonocytic leukemia patients. Hum Mutation (2018) 39:579\u201387. \u00a010.1002/humu.23399", "ArticleIdList": ["10.1002/humu.23399", "29316027"]}, {"Citation": "Shcherbina A, Miki H, Kenney DM, Rosen FS, Takenawa T, Remold-O\u2019Donnell E. WASP and N-WASP in human platelets differ in sensitivity to protease calpain. Blood (2001) 98(10):2988\u201391. \u00a010.1182/blood.v98.10.2988", "ArticleIdList": ["10.1182/blood.v98.10.2988", "11698281"]}, {"Citation": "Ben-David Y, Giddens EB, Letwin K, Bernstein A. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev (1991) 5:908\u201318. \u00a010.1101/gad.5.6.908", "ArticleIdList": ["10.1101/gad.5.6.908", "2044959"]}, {"Citation": "Athanasiou M, Mavrothalassitis G, Sun-Hoffman L, Blair DG. FLI-1 is a suppressor of erythroid differentiation in human hematopoietic cells. Leukemia (2000) 14:439\u201345. \u00a010.1038/sj.leu.2401689", "ArticleIdList": ["10.1038/sj.leu.2401689", "10720139"]}, {"Citation": "Athanasiou M, Clausen PA, Mavrothalassitis GJ, Zhang XK, Watson DK, Blair DG. Increased expression of ETS-related transcriptional factor FLI-1/ERGB correlates with and can induce the megakaryocytic phenotype. Cell Growth Differentiation Mol Biol J Am Assoc Cancer Res (1996) 7:1525\u201334.", "ArticleIdList": ["8930402"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "9", "Day": "18"}, {"Year": "2021", "Month": "1", "Day": "19"}, {"Year": "2021", "Month": "3", "Day": "15", "Hour": "6", "Minute": "58"}, {"Year": "2021", "Month": "3", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "7", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["33717090", "PMC7953068", "10.3389/fimmu.2021.607836"]}}], "PubmedBookArticle": []}